CGON
CG Oncology, Inc.
Key Financials
Operating Income
$-190774000
↓ 66.4%
Net Income
$-160995000
↓ 82.9%
EPS (Diluted)
$-2.08
↓ 47.5%
Total Liabilities
$39.0M
↑ 82.0%
Shareholders' Equity
$752.6M
↑ 2.6%
Total Assets
$791.6M
↑ 4.9%
Long-term Debt
$3.0M
↑ Infinity%
Cash & Equivalents
$32.5M
↓ 87.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CGON |
| Company Name | CG Oncology, Inc. |
| CIK | 1991792 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (949) 409-3700 |